20 results
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:49pm
that the compound preferentially inhibits the inactivated state of the channel with 1000-fold higher affinity as compared to the resting state. Injury … for the disposal of these materials and wastes. We cannot eliminate the risk of contamination or injury from these materials. In the event
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:45pm
that the compound preferentially inhibits the inactivated state of the channel with 1000-fold higher affinity as compared to the resting state. Injury … for the disposal of these materials and wastes. We cannot eliminate the risk of contamination or injury from these materials. In the event
10-K
2023 FY
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Annual report
4:48pm
that the compound preferentially inhibits the inactivated state of the channel with 1000-fold higher affinity as compared to the resting state. Injury … for the disposal of these materials and wastes. We cannot eliminate the risk of contamination or injury from these materials. In the event of contamination
424B4
CHRO
Chromocell Therapeutics Corp.
20 Feb 24
Prospectus supplement with pricing info
5:30pm
cannot eliminate the risk of contamination or injury from these materials. In the event of contamination or injury resulting from our use of hazardous … or contamination. Accordingly, in the event of contamination or injury, we could be held liable for damages or be penalized with fines in an amount
424B4
CHRO
Chromocell Therapeutics Corp.
20 Feb 24
Prospectus supplement with pricing info
5:28pm
for the disposal of these materials and wastes. We cannot eliminate the risk of contamination or injury from these materials. In the event … of contamination or injury resulting from our use of hazardous materials, we could be held liable for any resulting damages, and any liability could exceed our
DRS/A
xdaj1s0lbr04onozg3y
17 Oct 22
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next